ClariTrial | Search Clinical Trials

Explore/C4 Therapeutics

Status

Phase

758 results for “C4 Therapeutics”

Page 1 of 51

Completed

Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.

Phase 3Human Immunodeficiency Virus

Omega-3 fatty acidsTLC nutritional interventionOmega-3 fatty acid supplementation with fish oil and TLC nutritional intervention.

Instituto Mexicano del Seguro Social200 participantsCompletes May 2009

Compare CT.gov Full analysis →

Not Yet Recruiting

Prevention and Treatment for Bruises in Patients With Ischemic Stroke

Phase 4StrokeBruisesSkin Lesions

Ascorbic acid (Vitamin C)Normal Saline (Placebo)

Chiayi Christian Hospital400 participantsCompletes Jul 2028

Compare CT.gov Full analysis →

Not Yet Recruiting

Universal STAR-T Cell Injection in Autoimmune Kidney Diseases

N/AIgA Nephropathy (IgAN)Primary Membranous Nephropathy

Universal STAR-T Cell

Guangdong Provincial People's Hospital24 participants1 site · ChinaCompletes May 2029

Compare CT.gov Full analysis →

Active

Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq

Phase 4PhenylketonuriaPKU

RDD to Palynziq

BioMarin Pharmaceutical9 participants1 site · United StatesCompletes Aug 2026

Compare CT.gov Full analysis →

Terminated

Results posted

A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer

Phase 2Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma

FluorouracilLeucovorinOxaliplatin+2 more

Baylor College of Medicine3 participants5 sites · United StatesCompletes Feb 2025

Compare CT.gov Full analysis →

Active

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

Phase 1Systemic Lupus ErythematosusCAR-T Cell Therapy

anti-CD19-CAR-T cells

The Children's Hospital of Zhejiang University School of Medicine22 participants1 site · ChinaCompletes Apr 2025

Compare CT.gov Full analysis →

Active

Treatment of Bile Acid Diarrhoea With Atorvastatin

Phase 4Bile Acid DiarrheaBile Acid Malabsorption

AtorvastatinPlacebo

Asger Lund, MD20 participants1 site · DenmarkCompletes Dec 2026

Compare CT.gov Full analysis →

Withdrawn

tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis

N/AChronic PancreatitisPain

tDCSMeditation

Beth Israel Deaconess Medical Center01 site · United StatesCompletes Jan 2014

Compare CT.gov Full analysis →

Recruiting

Investigating the Effects of Transcranial Stimulation to Advance Stroke Rehabilitation

N/AStrokeUpper Limb Function

Transcranial Alternating Current Stimulation (beta-tACS)Transcranial Alternating Current Stimulation (sham)

University of Oxford60 participants1 site · United KingdomCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase 1Phase 2Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer

PaclitaxelCarboplatinBevacizumab+1 more

Imunon30 participants4 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD

N/AAutism Spectrum Disorder

Transdermal Neuromodulation Stimulation

Phoenix Children's Hospital10 participants1 site · United StatesCompletes Jul 2021

Compare CT.gov Full analysis →

Active

Results posted

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Phase 3Primary Biliary Cirrhosis

Elafibranor 80mgPlacebo

Ipsen161 participants115 sites · United States, Argentina, BelgiumCompletes Jun 2023

Compare CT.gov Full analysis →

Completed

A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus

Phase 1Systemic Lupus Erythematosus

Telitacicept

RemeGen Co., Ltd.16 participants12 sites · ChinaCompletes Nov 2025

Compare CT.gov Full analysis →

Recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Phase 3Systemic Lupus Erythematosus

AnifrolumabPlacebo

AstraZeneca100 participants100 sites · United States, Argentina, BrazilCompletes Oct 2028

Compare CT.gov Full analysis →

Completed

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

Phase 3Sjögren's Syndrome

Abatacept SC

University Medical Center Groningen80 participants1 site · NetherlandsCompletes Feb 2019

Compare CT.gov Full analysis →

1–15 of 758

Explore/C4 Therapeutics

Status

Phase

758 results for “C4 Therapeutics”

Page 1 of 51

Completed

Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.

Phase 3Human Immunodeficiency Virus

Omega-3 fatty acidsTLC nutritional interventionOmega-3 fatty acid supplementation with fish oil and TLC nutritional intervention.

Instituto Mexicano del Seguro Social200 participantsCompletes May 2009

Compare CT.gov Full analysis →

Not Yet Recruiting

Prevention and Treatment for Bruises in Patients With Ischemic Stroke

Phase 4StrokeBruisesSkin Lesions

Ascorbic acid (Vitamin C)Normal Saline (Placebo)

Chiayi Christian Hospital400 participantsCompletes Jul 2028

Compare CT.gov Full analysis →

Not Yet Recruiting

Universal STAR-T Cell Injection in Autoimmune Kidney Diseases

N/AIgA Nephropathy (IgAN)Primary Membranous Nephropathy

Universal STAR-T Cell

Guangdong Provincial People's Hospital24 participants1 site · ChinaCompletes May 2029

Compare CT.gov Full analysis →

Active

Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq

Phase 4PhenylketonuriaPKU

RDD to Palynziq

BioMarin Pharmaceutical9 participants1 site · United StatesCompletes Aug 2026

Compare CT.gov Full analysis →

Terminated

Results posted

A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer

Phase 2Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma

FluorouracilLeucovorinOxaliplatin+2 more

Baylor College of Medicine3 participants5 sites · United StatesCompletes Feb 2025

Compare CT.gov Full analysis →

Active

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

Phase 1Systemic Lupus ErythematosusCAR-T Cell Therapy

anti-CD19-CAR-T cells

The Children's Hospital of Zhejiang University School of Medicine22 participants1 site · ChinaCompletes Apr 2025

Compare CT.gov Full analysis →

Active

Treatment of Bile Acid Diarrhoea With Atorvastatin

Phase 4Bile Acid DiarrheaBile Acid Malabsorption

AtorvastatinPlacebo

Asger Lund, MD20 participants1 site · DenmarkCompletes Dec 2026

Compare CT.gov Full analysis →

Withdrawn

tDCS for the Management of Chronic Visceral Pain in Patients With Chronic Pancreatitis

N/AChronic PancreatitisPain

tDCSMeditation

Beth Israel Deaconess Medical Center01 site · United StatesCompletes Jan 2014

Compare CT.gov Full analysis →

Recruiting

Investigating the Effects of Transcranial Stimulation to Advance Stroke Rehabilitation

N/AStrokeUpper Limb Function

Transcranial Alternating Current Stimulation (beta-tACS)Transcranial Alternating Current Stimulation (sham)

University of Oxford60 participants1 site · United KingdomCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase 1Phase 2Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer

PaclitaxelCarboplatinBevacizumab+1 more

Imunon30 participants4 sites · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD

N/AAutism Spectrum Disorder

Transdermal Neuromodulation Stimulation

Phoenix Children's Hospital10 participants1 site · United StatesCompletes Jul 2021

Compare CT.gov Full analysis →

Active

Results posted

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Phase 3Primary Biliary Cirrhosis

Elafibranor 80mgPlacebo

Ipsen161 participants115 sites · United States, Argentina, BelgiumCompletes Jun 2023

Compare CT.gov Full analysis →

Completed

A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus

Phase 1Systemic Lupus Erythematosus

Telitacicept

RemeGen Co., Ltd.16 participants12 sites · ChinaCompletes Nov 2025

Compare CT.gov Full analysis →

Recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Phase 3Systemic Lupus Erythematosus

AnifrolumabPlacebo

AstraZeneca100 participants100 sites · United States, Argentina, BrazilCompletes Oct 2028

Compare CT.gov Full analysis →

Completed

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

Phase 3Sjögren's Syndrome

Abatacept SC

University Medical Center Groningen80 participants1 site · NetherlandsCompletes Feb 2019

Compare CT.gov Full analysis →

1–15 of 758